1. The IC-50-time evolution is a new model to improve drug responses consistency of large scale studies
    ABDELKRIM ALILECHE, 2022, F1000Research CrossRef
  2. Machine Learning Enabled Structure-Based Drug Repurposing Approach to Identify Potential CYP1B1 Inhibitors
    Baddipadige Raju et al, 2022, ACS Omega CrossRef
  3. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors
    Lu Zhou et al, 2019, Pathology - Research and Practice CrossRef
  4. Synthesis of N-Methylene Linker Containing Phthalimide Bearing-1H-1,2,3-Triazole by Click Chemistry Approach: Anticancer Activity in Human Cells
    Navneet P. Mori et al, 2023, Polycyclic Aromatic Compounds CrossRef
  5. Drug Repurposing Opportunities in Cancer
    Popat Kumbhar et al, 2023, Drug Repurposing for Emerging Infectious Diseases and Cancer CrossRef
  6. Quinolones as a Potential Drug in Genitourinary Cancer Treatment—A Literature Review
    Tomasz Kloskowski et al, 2022, Frontiers in Oncology CrossRef
  7. N-Acylated Ciprofloxacin Derivatives: Synthesis and In Vitro Biological Evaluation as Antibacterial and Anticancer Agents
    Marta Struga et al, 2023, ACS Omega CrossRef
  8. Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates
    Pranav Gupta et al, 2019, International Journal of Molecular Sciences CrossRef
  9. Phytochemical-rich Fractions from Foxtail Millet (Setaria italica (L.) P. Beauv) Seeds Exhibited Antioxidant Activity and Reduced the Viability of Breast Cancer Cells In Vitro by Inducing DNA Fragmentation and Promoting Cell Cycle Arrest
    Mahadevaswamy G. Kuruburu et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef
  10. miR-21 regulates ischemic neuronal injury via the p53/Bcl-2/Bax signaling pathway
    Honglin Yan et al, 2021, Aging CrossRef
  11. Enhancing the Anticancer Efficacy of Ciprofloxacin Towards Three Cancer Cell Lines via Avocado Oil Nanoemulsion Formulation
    Hadil Faris Alotaibi et al, 2024, International Journal of Pharmacology CrossRef
  12. Taurine Attenuates Calpain-2 Induction and a Series of Cell Damage via Suppression of NOX-Derived ROS in ARPE-19 Cells
    Yuanyuan Zhang et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
  13. Anti-proliferative and Apoptotic Activity Against an Acute Myeloid Leukemia Cell Line by Constituents from Ficus benghalensis
    Heba Ali Hassan et al, 2022, Revista Brasileira de Farmacognosia CrossRef
  14. Anticancer Effects of α-Pinene in AGS Gastric Cancer Cells
    Eun-Ji Han et al, 2024, Journal of Medicinal Food CrossRef
  15. Drug Repurposing of Selected Antibiotics: An Emerging Approach in Cancer Drug Discovery
    Nilofer Bano et al, 2024, ACS Omega CrossRef
  16. Ciprofloxacin/Topoisomerase-II complex as a promising dual UV–Vis/fluorescent probe: accomplishments and opportunities for the cancer diagnosis
    T. A. Sales et al, 2022, Theoretical Chemistry Accounts CrossRef
  17. Effect of four fluoroquinolones on the viability of bladder cancer cells in 2D and 3D cultures
    Tomasz Kloskowski et al, 2023, Frontiers in Oncology CrossRef
  18. Design and synthesis of novel cytotoxic fluoroquinolone analogs through topoisomerase inhibition, cell cycle arrest, and apoptosis
    Mohamed A. Elanany et al, 2023, Scientific Reports CrossRef
  19. Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer-Related Targets
    Žiga Skok et al, 2020, Journal of Medicinal Chemistry CrossRef
  20. Design, Synthesis, Characterization, and Crystal Structure Studies of Nrf2 Modulators for Inhibiting Cancer Cell Growth In Vitro and In Vivo
    Prathima Chikkegowda et al, 2021, ACS Omega CrossRef
  21. The Assessment of Cytotoxicity, Apoptosis Inducing Activity and Molecular Docking of a new Ciprofloxacin Derivative in Human Leukemic Cells
    Neda Pashapour et al, 2024, Journal of Fluorescence CrossRef
  22. Targeted Antitumor Mechanism of C-PC/CMC-CD55sp Nanospheres in HeLa Cervical Cancer Cells
    Guoxiang Liu et al, 2020, Frontiers in Pharmacology CrossRef
  23. Ciprofloxacin and Norfloxacin Hybrid Compounds: Potential Anticancer Agents
    Sijongesonke Peter et al, 2024, Current Topics in Medicinal Chemistry CrossRef